Drug Eruption and Interactions - PHARMACEUTICAL REVIEW
Share Embed Flag
Download ePaper

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

pharmareview.files.wordpress.com
from pharmareview.files.wordpress.com More from this publisher
02.06.2013 Views

Lupus erythematosus (1980): Condemi JJ, Geriatrics 35(3), 81 Lymphocytoma cutis (1988): Raymond JZ+, Cutis 41, 323 Necrotizing vasculitis Perforating foot ulceration (1997): Bouloc A+, Clin Exp Dermatol 21, 351 Petechiae Photosensitivity (1986): Lerman S, Ophthalmology 93, 304 Pityriasis rosea (2006): Atzori L+, Dermatology Online Journal 12(1), 1 (with hydrochlorothiazide) Pruritus (10%) Pustules (2002): Lun K+, Australas J Dermatol 43(2), 140 Pustuloderma (1994): Fitzgerald DA+, Clin Exp Dermatol 19, 243 Rash (sic) (>10%) (2005): Choi SH+, Korean J Hepatol 11(1), 80 (2003): Mete N+, J Investig Allergol Clin Immunol 13(4), 281 (2001): Dominguez Ortega J+, An Med Intern 18(1), 27 (1996): Yale SH+, Hosp Pract Off Ed 31, 92 Sensitivity (sic) Stevens–Johnson syndrome (>10%) (2007): Dainichi T+, Dermatology 215(1), 86 (2005): Lin MS+, Intern Med J 35(3), 188 (2003): Fine P+, Optometry 74(10), 659 (2003): Yeung CK+, Acta Derm Venereol 83(3), 179 (8 cases) (1999): Halevy S+, Int J Dermatol 38(11), 835 (1995): Gonzalez U+, Rev Invest Clin 47(5), 409 (1995): Roujeau JC+, NEnglJMed333(24), 1600 (1993): Leenutaphong V+, Int J Dermatol 32, 428 (1992): Goodglick TA+, Ophthalmic Surg 23, 557 (1989): Chan SH+, Dermatologica 179, 32 (1985): Edwards R+, Dimens Crit Care Nurs 4, 335 (1985): Renwick IG, BMJ 291, 485 (1985): Ting HC+, Int J Dermatol 24, 587 (1984): Pennell DJ+, Lancet 1, 463 (fatal) Toxic epidermal necrolysis (2007): Dainichi T+, Dermatology 215(1), 86 (2007): Paquet P+, Burns 33(1), 100 (2005): Kakeda M+, JDermatol32(8), 654 (2005): Lin MS+, Intern Med J 35(3), 188 (2005): Nasser M+, Am J Med Sci 329(2), 95 (2003): Yeung CK+, Acta Derm Venereol 83(3), 179 (8 cases) (2002): Correia O+, Arch Dermatol 138, 29 (2 cases) (2001): Hammer B+, Dtsch Med Wochenschr 126(47), 1331 (1999): Sorkin MJ, Denver, CO (from Internet) (observation) (1995): Roujeau JC+, NEnglJMed333(24), 1600 (1995): Wolkenstein P+, Arch Dermatol 131, 544 (1994): Alfandari S+, Infection 22, 365 (1993): Correia O+, Dermatology 186, 32 (1993): Leenutaphong V+, Int J Dermatol 32, 428 (1991): Sakellariou G+, Int J Artif Organs 14, 634 (1987): Guillaume JC+, Arch Dermatol 123, 1166 (1986): Kumar L, Indian J Dermatol 31, 53 (1985): Auboeck J+, BMJ 290, 1969 (1985): Renwick IG, BMJ 291, 485 (1985): Zakraoui L+, Tunis Med (French) 63, 167 (1984): Chan HL, JAmAcadDermatol10, 973 (1984): Dan M+, Int J Dermatol 23, 142 Toxic erythema ALLOPURINOL 17 (1995): Rademaker M, NZMedJ108, 165 Toxic pustuloderma (1994): Boffa MJ+, Br J Dermatol 131, 447 (1994): Fitzgerald DA+, Clin Exp Dermatol 19, 243 (1993): Yu RC+, Br J Dermatol 128, 95 Urticaria (>10%) (2001): Dominguez Ortega J+, An Med Interna 18(1), 27 (1999): Litt JZ, Beachwood, OH (personal case) (observation) (1992): Breathnach SM+, Adverse Drug Reactions and the Skin Blackwell, Oxford, 193 (passim) (1991): Anderson MH+, Ann Allergy 66, 207 Vasculitis (

18 ALLOPURINOL (2001): Dominguez Ortega J+, An Med Interna 18(1), 27 (2001): Hammer B+, Dtsch Med Wochenschr 126(47), 1331 (2001): Rivas Gonzalez P+, Rev Clin Esp 201(8), 493 (1999): Gillott TJ+, Rheumatology (Oxford) 38, 85 (1999): Melsom RD, Rheumatology 38, 1301 (familial) (1999): Morel D+, NephrolDialTransplant14, 780 (1998): Kluger E, Ugeskr Laeger (Danish) 160, 1179 (1998): Pluim HJ+, Neth J Med 52, 107 (1997): Carpenter C, Tenn Med 90, 151 (1996): Kumar A+, BMJ 312, 173 (1995): Elasy T+, West J Med 162, 360 (1994): Lee SS+, Chung Hua Min Kuo Wei Sheng Wu Chi Mien I Hsueh Tsa Chih 27, 140 (1994): Salinas Martin A+, Aten Primaria (Spanish) 14, 694 (1989): Puig JG+, J Rheumatol 16, 842 (1988): McDonald J+, J Rheumatol 15, 865 (1985): Stein CM, SAfrMedJ67, 935 (1984): Vinciullo C, Aust J Dermatol 25, 59 (1984): Vinciullo C, Med J Aust 141, 449 Myalgia/Myositis/Myopathy/Myotoxicity (2002): Terawaki H+, Nippon Jinzo Gakkai Shi 44, 50 (1996): Ghanem BM+, J Egypt Soc Parasitol 26, 619 Polyarteritis nodosa Pseudolymphoma (1993): Kerl H+, Dermatology in General Medicine McGraw-Hill New York Thrombophlebitis (

18 ALLOPURINOL<br />

(2001): Dominguez Ortega J+, An Med Interna 18(1), 27<br />

(2001): Hammer B+, Dtsch Med Wochenschr 126(47), 1331<br />

(2001): Rivas Gonzalez P+, Rev Clin Esp 201(8), 493<br />

(1999): Gillott TJ+, Rheumatology (Oxford) 38, 85<br />

(1999): Melsom RD, Rheumatology 38, 1301 (familial)<br />

(1999): Morel D+, NephrolDialTransplant14, 780<br />

(1998): Kluger E, Ugeskr Laeger (Danish) 160, 1179<br />

(1998): Pluim HJ+, Neth J Med 52, 107<br />

(1997): Carpenter C, Tenn Med 90, 151<br />

(1996): Kumar A+, BMJ 312, 173<br />

(1995): Elasy T+, West J Med 162, 360<br />

(1994): Lee SS+, Chung Hua Min Kuo Wei Sheng Wu Chi Mien I<br />

Hsueh Tsa Chih 27, 140<br />

(1994): Salinas Martin A+, Aten Primaria (Spanish) 14, 694<br />

(1989): Puig JG+, J Rheumatol 16, 842<br />

(1988): McDonald J+, J Rheumatol 15, 865<br />

(1985): Stein CM, SAfrMedJ67, 935<br />

(1984): Vinciullo C, Aust J Dermatol 25, 59<br />

(1984): Vinciullo C, Med J Aust 141, 449<br />

Myalgia/Myositis/Myopathy/Myotoxicity<br />

(2002): Terawaki H+, Nippon Jinzo Gakkai Shi 44, 50<br />

(1996): Ghanem BM+, J Egypt Soc Parasitol 26, 619<br />

Polyarteritis nodosa<br />

Pseudolymphoma<br />

(1993): Kerl H+, Dermatology in General Medicine McGraw-Hill<br />

New York<br />

Thrombophlebitis (

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!